() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

News

Canopy Growth’s Analyst Ratings and Price Target

Canopy Growth's Analyst Ratings and Price Target Canopy Growth Canopy Growth (WEED) has a market capitalization of 5.7 billion Canadian dollars. The stock rose ~132.0% to 28.80 Canadian dollars on February 6. Over a one-year period, the positive regulatory sentiment toward the cannabis industry (HMLSF) also garnered price upgrades from analysts. Let’s look at where…
Read more

Analyst Ratings and Price Targets for Major Cannabis Stocks

Analyst Ratings and Price Targets for Major Cannabis Stocks In Why Cannabis Stocks Fell in the Week Ended February 2, we discussed how last week’s marketwide shock also negatively impacted cannabis stocks. We also looked at the valuation multiples in the cannabis industry and how they looked stretched. Cannabis stocks rise In contrast to last week, cannabis…
Read more

Digging into Aphria’s Cost of Production

Aphria’s costs In this part of the series, we’ll discuss how Aphria’s (APHQF) production costs have evolved in the last four quarters, just as we did for MedReleaf (MEDFF), Aurora Cannabis (ACB), and Canopy Growth (WEED) earlier. Cost evolution In the chart above, we can see that though Aphria’s costs per gram have seen a…
Read more

Congress Protects Medical Marijuana From Jeff Sessions In New Federal Spending Bill

Congress Protects Medical Marijuana From Jeff Sessions In New Federal Spending Bill Medical marijuana patients and businesses that follow state laws will continue to be protected from U.S. Attorney General Jeff Sessions and the federal drug agents that work for him under a provision contained in new must-pass legislation revealed on Wednesday. Photo by Gordon…
Read more